Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Evidence for the Importance of Vitamin D Status in Neurologic Conditions.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
The role of myelin and oligodendrocytes in axonal energy metabolism.
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.
Expression of a single ICAMâ1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
An unusual presentation of X-linked adrenoleukodystrophy.
Dimethylfumarate Impairs Neutrophil Functions.
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.
Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling.
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Lifestyle shapes the dialog between environment, microglia, and adult neurogenesis.
Axon growth inhibition by RhoA/ROCK in the central nervous system.
Alternatively activated microglia and macrophages in the central nervous system.
Patterns of Objective and Subjective Burden of Informal Caregivers in Multiple Sclerosis.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland.
Effectiveness of rehabilitation in multiple sclerosis relapse on fatigue, self-efficacy and physical activity.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Pages
« first
‹ previous
…
702
703
704
705
706
707
708
709
710
…
next ›
last »